DBV Technologies (DBVT) FCF Margin Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -303,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -303,750.00 |
| Dec 31, 2025 | -313,782.00 |
| Sep 30, 2025 | 95,834.00 |
| Jun 30, 2025 | 76,896.00 |
| Mar 31, 2025 | 9,805.00 |
| Dec 31, 2024 | -221,502.00 |
| Sep 30, 2024 | -130,453.00 |
| Jun 30, 2024 | -195,998.00 |
| Mar 31, 2024 | -160,559.00 |
| Dec 31, 2023 | -199,077.00 |
| Sep 30, 2023 | 15,734.00 |
| Jun 30, 2023 | -43,806.00 |
| Mar 31, 2023 | -89,157.00 |
| Dec 31, 2022 | 250,449.00 |
| Sep 30, 2022 | 74,902.00 |
| Jun 30, 2022 | 133,879.00 |
| Mar 31, 2022 | 117,387.00 |
| Dec 31, 2021 | -343,848.00 |
| Sep 30, 2021 | -71,805.00 |
| Mar 31, 2021 | -16,737.00 |
| Sep 30, 2020 | 4,052.00 |
| Sep 30, 2019 | 237,974.00 |
| Dec 31, 2015 | 115.00 |